Collaboration in Action: Decentralized Manufacturing to Expand Patient Access in Cell Therapy
Scaling a cell or gene therapy requires more than just science; it requires a robust logistics and manufacturing strategy. Join industry veterans from Excellos, Lonza, Galapagos, and BCA as they share the unvarnished truth about navigating the path to commercialization. This discussion peels back the layers of complex supply chains to reveal what actually works in 2025. Key Takeaways: Strategic […]
Donor to Dose: Why CMC Matters in Cell and Gene Therapy Featuring Tr1x
Why Does CMC Matters So Much in Cell and Gene Therapy? Because it’s the point where science meets manufacturability—the place where a promising idea becomes something that can actually be delivered to patients. Strong CMC isn’t just a regulatory requirement; it’s what ensures consistency, comparability, and true scalability from the very beginning. At the Advanced […]
Considerations for Donor Starting Material Characterization
How well do you know your starting material? Watch Rob Tressler, Chief Scientific Officer at Excellos, present “Considerations for Donor Starting Material Characterization” from CGT Summit 2025 in Orlando. In this session, Rob explores key factors influencing the quality and consistency of cell and gene therapy products—insights that are essential for advancing the future of […]
Donor to Dose: A New Morning Briefing Series
Kick off your day with Donor to Dose, a fresh series of expert conversations exploring the critical science and strategies behind successful cell and gene therapy manufacturing. In this first session, Excellos Chief Scientific Officer Dr. Robert Tressler dives into Excellos360™, our innovative multiparametric analysis platform that evaluates T cell metabolism, function, and stemness to deliver a […]
Excell-ence Exclusive: July 2025 Highlights
Cell Therapy Manufacturing Insights and Updates Welcome back to The Excell-ence Exclusive! Your quarterly source for expert insights into cell therapy manufacturing. In each issue, we share thought-provoking articles from the Excellos scientific team, highlighting technical expertise, industry trends, and best practices to help you accelerate your projects and stay ahead in the fast-moving […]
Spotlight on Excellence: Process Development group
Spotlight on Excellence: Process Development group Who powers the science behind scalable, GMP-ready cell therapies? Not just the tech. Not just the tools. It’s the people transforming innovation into impact. Because in cell therapy, science doesn’t scale itself. At Excellos, advancing cell therapy starts with strong science—and that expertise comes to life in our Process […]
A Network for Innovation: Excellos’ Partnership with Blood Centers of America
A Network for Innovation: Excellos’ Partnership with Blood Centers of America Strong partnerships are essential to delivering consistent, high-quality starting material for cell and gene therapy—and our collaboration with Blood Centers of America (BCA), through San Diego Blood Bank, is a great example of that impact in action. Our Blood Centers of America Partnership Journey […]
The Excell-ence Exclusive: Advancing Cell Therapy Innovations | May 2025
Welcome back to The Excell-ence Exclusive! Your quarterly source for expert insights into cell therapy manufacturing. In each issue, we share thought-provoking articles from the Excellos scientific team, highlighting technical expertise, industry trends, and best practices to help you accelerate your projects and stay ahead in the fast-moving world of cell therapy. Contact us for […]
Starting Strong: Why Your Cell Therapy Begins with the Right Material
When it comes to cell therapy, your starting material can make all the difference — not just in outcomes, but in efficiency, reproducibility, and long-term success. At Excellos, we believe the quality and consistency of your donor material should never be an afterthought. Through our deep partnership with San Diego Blood Bank, we offer more […]
Proud to Be Part of ARM: Advancing the Future of Regenerative Medicine Together
Proud to Be Part of ARM: Advancing the Future of Regenerative Medicine Together At Excellos, we are honored to be a member of the Alliance for Regenerative Medicine—a driving force behind the progress, innovation, and advocacy that is transforming the field of regenerative medicine. Alliance for Regenerative Medicine also known as ARM As a member […]